Scrambler Therapy for Chemotherapy-Induced Peripheral Neuropathy

Abroad (travel likely)Recruiting

Conditions

Chemotherapy-induced Peripheral Neuropathy · CIPN - Chemotherapy-Induced Peripheral Neuropathy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland, Ohio, United States
Contact: Study coordinator (Laura Shoemaker, DO, MS, FAAHPM) · shoemal@ccf.org · (216) 444-5193
Contact: Principal Investigator (Laura Shoemaker, DO, MS, FAAHPM)

Study leads

Laura Shoemaker, DO, MS, FAAHPM
Principal Investigator
Case Comprehensive Cancer Center, Cleveland Clinic

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Clinical Biomarker of Paclitaxel-induced Peripheral Neuropathy

Chemotherapy-induced Peripheral Neuropathy

Abroad (travel likely)Recruiting

Odense, Denmark · Sønderborg, Denmark

Scrambler Therapy With Duloxetine-based Usual Care vs Duloxetine-based Usual Care for Chemotherapy-induced Peripheral Neuropathy.

CIPN - Chemotherapy-Induced Peripheral Neuropathy · Pain

Abroad (travel likely)RecruitingPHASE2

Philadelphia, United States

Predicting Peripheral Neuropathy of Paclitaxel for Gastric Cancer

Gastric Cancer · Chemotherapy-induced Peripheral Neuropathy · Paclitaxel

Abroad (travel likely)Recruiting

Kurashiki, Japan

A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment

Chemotherapy-Induced Peripheral Neuropathy · Hematopoietic and Lymphatic System Neoplasm · Malignant Solid Neoplasm

Abroad (travel likely)Recruiting

Ann Arbor, United States